EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

microRNA-22 Inhibition Stimulates Mitochondrial Homeostasis and Intracellular Degradation Pathways to Prevent Muscle Wasting

Simone Tomasini iD, Emanuele Monteleone iD, Anna Altieri, Francesco Margiotta iD, Fereshteh Dardmeh, Hiva Alipour iD, Anja Holm iD, Sakari Kauppinen, Riccardo Panella

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26209900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Simone Tomasini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for RNA Medicine, Department of Clinical Medicine, Aalborg University, 2450 Copenhagen, Denmark. Hauptthemen laut MEDLINE: MicroRNAs, Muscular Atrophy, Homeostasis, Mitochondria. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, Fondazione Umberto Veronesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNA-22 (miR-22) is a negative regulator of mitochondrial biogenesis, as well as lipid and glucose metabolism, in metabolically active tissues. Silencing miR-22 holds promise as a potential treatment of obesity and metabolic syndrome, as it restores metabolic capacity—enhancing oxidative metabolism—and reduces ectopic fat accumulation in chronic obesity, a driver of impaired metabolic flexibility and muscle mass loss. Intramuscular adipose accumulation and defective mitochondrial function are features associated with obese-mediated muscle atrophy and hallmarks of neuromuscular disorders such as Duchenne muscular dystrophy. Therefore, miR-22 could represent a compelling molecular target to improve muscle health across various muscle-wasting conditions. This study describes a pharmacological strategy for the inhibition of miR-22 in skeletal muscle by employing a mixmer antisense oligonucleotide (ASO, anti-miR-22). Administration of the ASO in a mouse model of obesity positively modulated myogenesis while protecting dystrophic mice from muscle function decline, enhancing fatigue resistance, and limiting pathological fibrotic remodeling. Mechanistically, we show that anti-miR-22 treatment promotes derepression of genes involved in mitochondrial homeostasis, favoring oxidative fiber content regardless of the disease model, thus promoting a more resilient phenotype. Furthermore, we suggest that miR-22 inhibition increases autophagy by transcriptional activation of multiple negative regulators of mammalian target of rapamycin (mTOR) signaling to decrease immune infiltration and fibrosis. These findings position miR-22 as a promising therapeutic target for muscle atrophy and support its potential to restore muscle health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMuscular AtrophyHomeostasisMitochondriaAnimalsMiceMuscle, SkeletalObesityMice, Inbred C57BLMaleDisease Models, AnimalMuscle DevelopmentTOR Serine-Threonine KinasesOligonucleotides, AntisenseAutophagyMice, Inbred mdx

Stichwörter der Autor:innen

ASODMDantimiRsautophagyfibrosismiR-22miRNA therapeuticsmicroRNAmuscle atrophyoxidative metabolism

Substanzen

MicroRNAsMirn22 microRNA, mouseTOR Serine-Threonine KinasesOligonucleotides, Antisense

Autor:innen und Institutionen

  • Center for RNA Medicine, Department of Clinical Medicine, Aalborg University, 2450 Copenhagen, Denmark.
  • Department of Life Sciences and Systems Biology, University of Turin, 10124 Torino, Italy.
  • Resalis Therapeutics Srl, Via E. De Sonnaz 19, 10121 Torino, Italy.
  • Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Pharmacology and Toxicology Section, University of Florence, Viale G. Pieraccini 6, 50139 Firenze, Italy.
  • Department of Health Science and Technology, Aalborg University, 9220 Aalborg, Denmark.
  • RNA Therapeutics, Translational Research Centre, Rigshospitalet, 2600 Glostrup, Denmark.

ORCID-Profile: Simone Tomasini, Emanuele Monteleone, Francesco Margiotta, Hiva Alipour, Anja Holm

Förderung

  • Novo Nordisk Foundation
  • Fondazione Umberto Veronesi

Zitieren

APA

Tomasini, S., Monteleone, E., Altieri, A., Margiotta, F., Dardmeh, F., Alipour, H., Holm, A., Kauppinen, S., & Panella, R. (2025). microRNA-22 Inhibition Stimulates Mitochondrial Homeostasis and Intracellular Degradation Pathways to Prevent Muscle Wasting. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26209900

Vancouver

Tomasini S, Monteleone E, Altieri A, Margiotta F, Dardmeh F, Alipour H, et al. microRNA-22 Inhibition Stimulates Mitochondrial Homeostasis and Intracellular Degradation Pathways to Prevent Muscle Wasting. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26209900

BibTeX
@article{Tomasini2025,
  author = {Tomasini, Simone and Monteleone, Emanuele and Altieri, Anna and Margiotta, Francesco and Dardmeh, Fereshteh and Alipour, Hiva and Holm, Anja and Kauppinen, Sakari and Panella, Riccardo},
  title = {microRNA-22 Inhibition Stimulates Mitochondrial Homeostasis and Intracellular Degradation Pathways to Prevent Muscle Wasting},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26209900}
}
Kostenlos starten →